JPAD-Journal of Prevention of Alzheimers Disease

Scope & Guideline

Empowering Knowledge to Combat Alzheimer's Disease

Introduction

Welcome to your portal for understanding JPAD-Journal of Prevention of Alzheimers Disease, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN2274-5807
PublisherSPRINGER BASEL AG
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationJPAD-J PREV ALZHEIM / JPAD-J. Prev. Alzheimers Dis.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPICASSOPLATZ 4, BASEL 4052, SWITZERLAND

Aims and Scopes

The Journal of Prevention of Alzheimer's Disease (JPAD) is dedicated to advancing the understanding and prevention of Alzheimer's disease through comprehensive research that encompasses a range of biological, psychological, and social factors. The journal focuses on innovative methodologies and interdisciplinary approaches to address the complexities of Alzheimer's disease and cognitive decline.
  1. Prevention Strategies and Interventions:
    The journal emphasizes the development and evaluation of various prevention strategies aimed at delaying or preventing cognitive decline and Alzheimer's disease. This includes lifestyle modifications, dietary interventions, and community-based programs.
  2. Biomarkers and Diagnostic Tools:
    Research on biomarkers for early detection and diagnosis of Alzheimer's disease is a core focus. This includes studies on blood, imaging, and genetic biomarkers that can help identify individuals at risk and monitor disease progression.
  3. Cognitive Function Assessment:
    JPAD publishes studies that explore cognitive assessments and their relevance in clinical and community settings. This includes the validation of new cognitive tests and the use of digital tools to evaluate cognitive function.
  4. Health Equity and Access:
    The journal addresses disparities in Alzheimer's disease research and treatment, focusing on recruitment strategies for underrepresented populations in clinical trials and the role of social determinants of health.
  5. Innovative Therapeutic Approaches:
    Research into new therapeutic strategies, including pharmacological and non-pharmacological interventions, is a significant area of interest. This includes studies on the efficacy of new drugs, dietary supplements, and lifestyle changes.
  6. Longitudinal Studies and Cohort Analyses:
    JPAD often features longitudinal studies that track cognitive decline over time, providing insights into the progression of Alzheimer's disease and associated risk factors.
The Journal of Prevention of Alzheimer's Disease is witnessing a dynamic shift towards several emerging themes that reflect current trends in Alzheimer's research. These themes highlight innovative approaches and interdisciplinary research efforts.
  1. Digital Health Interventions:
    The use of digital technologies for cognitive assessments, monitoring, and interventions is rapidly gaining traction. Research exploring how mobile applications and online platforms can enhance cognitive health is increasingly prevalent.
  2. Personalized Medicine Approaches:
    There is a growing emphasis on personalized medicine in Alzheimer's research, with studies focusing on tailoring interventions based on individual genetic, lifestyle, and health profiles.
  3. Multidomain Lifestyle Interventions:
    Research on multidomain interventions that combine dietary, physical, and cognitive activities to prevent cognitive decline is on the rise, reflecting an integrated approach to Alzheimer's prevention.
  4. Community Engagement in Research:
    The journal is increasingly highlighting the importance of community engagement in Alzheimer's research, particularly in recruiting diverse populations for clinical trials and addressing health disparities.
  5. Neuroinflammation and Immune Response:
    Emerging research into the role of neuroinflammation and the immune response in Alzheimer's disease is gaining prominence, with studies investigating therapeutic strategies targeting these pathways.
  6. Social Determinants of Health:
    There is an increasing focus on how social determinants, such as socioeconomic status and access to care, impact cognitive health and the progression of Alzheimer's disease.

Declining or Waning

While the Journal of Prevention of Alzheimer's Disease continues to evolve, certain themes have shown a decline in prominence in recent publications. These waning scopes suggest a shift in research priorities and emerging areas of focus.
  1. Historical Epidemiological Studies:
    There has been a noticeable decrease in the publication of traditional epidemiological studies that solely focus on historical data without integrating contemporary methods or innovative approaches.
  2. Single-Factor Risk Assessments:
    Research solely emphasizing single-factor risk assessments for Alzheimer's disease is declining. The trend is moving towards multifactorial approaches that consider a combination of genetic, environmental, and lifestyle factors.
  3. Basic Science Research:
    Studies focused exclusively on basic biological mechanisms of Alzheimer's disease without practical implications for prevention or intervention are becoming less frequent, as the journal emphasizes translational research.
  4. Pharmacological Monotherapy Trials:
    There is a waning interest in studies that evaluate the effectiveness of pharmacological monotherapies for Alzheimer's treatment, as the focus shifts towards combination therapies and holistic approaches.

Similar Journals

Early Intervention in Psychiatry

Pioneering Early Detection for a Brighter Psychiatric Future
Publisher: WILEYISSN: 1751-7885Frequency: 12 issues/year

Early Intervention in Psychiatry, published by WILEY, is an esteemed academic journal dedicated to advancing the field of psychiatry and mental health through rigorous research and innovative practices. Established in 2007 and continuing through 2024, this journal serves as a critical resource for researchers, clinicians, and students interested in the early detection and treatment of psychiatric disorders. With an ISSN of 1751-7885 and an E-ISSN of 1751-7893, it is recognized for its significant contributions, placing in the Q3 quartile in Biological Psychiatry and Q2 in Psychiatry and Mental Health as of 2023. The journal boasts impressive Scopus rankings, being placed 12th in Nursing - Psychiatric Mental Health and 27th in Neuroscience - Biological Psychiatry, showcasing its impact within the scientific community. While not an open-access journal, its findings are pivotal for those seeking to enhance mental health interventions. Early Intervention in Psychiatry is committed to fostering knowledge and improving practices that ultimately contribute to better mental health outcomes globally.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Fostering interdisciplinary dialogue in dementia research.
Publisher: KARGERISSN: 1420-8008Frequency: 6 issues/year

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Advancing mental health research for aging populations.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

GeroPsych-The Journal of Gerontopsychology and Geriatric Psychiatry

Connecting Research and Practice in Gerontology
Publisher: HOGREFE AG-HOGREFE AG SUISSEISSN: 1662-9647Frequency: 4 issues/year

GeroPsych - The Journal of Gerontopsychology and Geriatric Psychiatry, published by HOGREFE AG, stands as an essential academic resource in the evolving fields of gerontology and geriatric psychiatry. With a commitment to advancing the understanding of psychological well-being in older adults, the journal provides a platform for high-quality research, discussion, and innovation that caters to researchers, practitioners, and students alike. Although currently not an open-access publication, GeroPsych ensures accessibility through various academic libraries and institutions, fostering a collaborative approach to the complexities of aging and mental health. Recognized within the Q3 category for Geriatrics and Gerontology, and with its impact reflected in Scopus rankings, this journal plays a pivotal role in informing best practices and shaping policies within the interdisciplinary landscape of geriatric care. Spanning research from 2010 to 2024, GeroPsych is positioned as a leading journal for those committed to improving the mental health and psychological resilience of the aging population.

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Unlocking the potential of dementia research for better patient outcomes.
Publisher: WILEYISSN: Frequency: 1 issue/year

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.

Aktualnosci Neurologiczne

Bridging Research and Practice in Neurology
Publisher: MEDICAL COMMUNICATIONSISSN: 1641-9227Frequency: 4 issues/year

Aktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.

NORDIC JOURNAL OF PSYCHIATRY

Shaping the future of psychiatric understanding since 1947.
Publisher: TAYLOR & FRANCIS LTDISSN: 0803-9488Frequency: 8 issues/year

NORDIC JOURNAL OF PSYCHIATRY is a pivotal publication in the field of psychiatry and mental health, dedicated to advancing knowledge and fostering dialogue among researchers, clinicians, and students. Published by Taylor & Francis Ltd, this esteemed journal, with an ISSN of 0803-9488 and E-ISSN 1502-4725, serves as a platform for innovative research and critical reviews that address crucial mental health issues affecting Nordic populations and beyond. Its impact is underscored by a notable Q2 ranking in the Psychiatry and Mental Health category for 2023, along with a respectable position within the Scopus ranking at #268 out of 567. The journal has been a reliable source of scientific inquiry since its inception in 1947, and it aims to facilitate significant advancements in the understanding and treatment of psychiatric disorders. By providing access to high-quality research without open access options, NORDIC JOURNAL OF PSYCHIATRY remains a must-read for those dedicated to progressing mental health science in a global context.

Neurodegenerative Disease Management

Championing Excellence in Neurological Research
Publisher: FUTURE MEDICINE LTDISSN: 1758-2024Frequency: 6 issues/year

Neurodegenerative Disease Management is a distinguished journal published by FUTURE MEDICINE LTD, focusing on the pivotal issues surrounding the management of neurodegenerative diseases. Since its inception in 2014, this journal has emerged as a significant resource within the fields of medicine and neurology, currently holding a respected position with a Q2 category ranking in Medicine (miscellaneous) and Q3 in Neurology (clinical) for 2023. With an ISSN of 1758-2024 and E-ISSN 1758-2032, the journal provides a platform for the dissemination of innovative research, clinical practices, and advancements in treatment strategies for conditions such as Alzheimer's, Parkinson's, and multiple sclerosis. The journal is particularly committed to enhancing knowledge sharing among researchers, health professionals, and students, contributing to the collective effort in combatting neurodegenerative diseases. Though not open access, its articles are meticulously curated to ensure high-quality, impactful contributions to the field, making it an essential reference for those engaged in neurology and related disciplines.

Psychogeriatrics

Empowering professionals with cutting-edge psychogeriatric research.
Publisher: WILEYISSN: 1346-3500Frequency: 4 issues/year

Psychogeriatrics is a leading peer-reviewed journal published by WILEY, dedicated to advancing the understanding of mental health and geriatric psychiatry. With an ISSN of 1346-3500 and an E-ISSN of 1479-8301, this journal has been integral to the field since its inception in 2005 and continues to publish cutting-edge research until 2024. Recognized for its impact, Psychogeriatrics holds a commendable Q2 quartile ranking in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health as of 2023. The journal's Scopus rankings reflect its significant contribution to Nursing Gerontology, Medicine Psychiatry and Mental Health, and Medicine Geriatrics and Gerontology. Although it operates with no open access options, Psychogeriatrics remains a vital resource for researchers, professionals, and students who are exploring the complexities of mental health in older populations. The journal not only disseminates innovative research but also tackles pressing issues related to the psychological well-being of the elderly, making it essential reading for anyone focused on improving geriatric mental health care.

Psychiatry Investigation

Connecting Research to Real-World Mental Health Solutions
Publisher: KOREAN NEUROPSYCHIATRIC ASSOCISSN: 1738-3684Frequency: 12 issues/year

Psychiatry Investigation is a prominent, peer-reviewed journal published by the Korean Neuropsychiatric Association, focusing on advancements in the fields of psychiatry and mental health. With an ISSN of 1738-3684 and an E-ISSN of 1976-3026, this journal has steadily gained recognition within the academic community since its inception in 2006. Spanning a dynamic spectrum of research topics, it aims to disseminate innovative findings and facilitate discussions that contribute to the understanding and treatment of psychiatric disorders. As evidenced by its current Scopus rankings—positioned in the Q2 category for Psychiatry and Mental Health and the Q3 category for Biological Psychiatry—the journal is committed to maintaining high scholarly standards and impactful research contributions. Although fully open access is not available, the relevance of its content ensures that it remains a critical resource for researchers, clinicians, and students alike, furthering knowledge and practices in the field of mental health.